Systematic review: gastric microbiota in health and disease

Data de publicação: Data Ahead of Print:

Autores da FMUP

  • Maria Do Céu Fontes Herdeiro Figueiredo

    Autor

  • José Carlos Lemos Machado

    Autor

Participantes de fora da FMUP

  • Rajilic Stojanovic, M
  • Smet, A
  • Hansen, R
  • Kupcinskas, J
  • Rokkas, T
  • Andersen, L
  • Ianiro, G
  • Gasbarrini, A
  • Leja, M
  • Gisbert, JP
  • Hold, GL

Unidades de investigação

Abstract

Background Helicobacter pylori is the most infamous constituent of the gastric microbiota and its presence is the strongest risk factor for gastric cancer and other gastroduodenal diseases. Although historically the healthy stomach was considered a sterile organ, we now know it is colonised with a complex microbiota. However, its role in health and disease is not well understood. Aim To systematically explore the literature on the gastric microbiota in health and disease as well as the gut microbiota after bariatric surgery. Methods A systematic search of online bibliographic databases MEDLINE/EMBASE was performed between 1966 and February 2019 with screening in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Randomised controlled trials, cohort studies and observational studies were included if they reported next-generation sequencing derived microbiota analysis on gastric aspirate/tissue or stool samples (bariatric surgical outcomes). Results Sixty-five papers were eligible for inclusion. With the exception of H pylori-induced conditions, overarching gastric microbiota signatures of health or disease could not be determined. Gastric carcinogenesis induces a progressively altered microbiota with an enrichment of oral and intestinal taxa as well as significant changes in host gastric mucin expression. Proton pump inhibitors usage increases gastric microbiota richness. Bariatric surgery is associated with an increase in potentially pathogenic proteobacterial species in patient stool samples. Conclusion While H pylori remains the single most important risk factor for gastric disease, its capacity to shape the collective gastric microbiota remains to be fully elucidated. Further studies are needed to explore the intricate host/microbial and microbial/microbial interplay.

Dados da publicação

ISSN/ISSNe:
0269-2813, 1365-2036

ALIMENTARY PHARMACOLOGY & THERAPEUTICS  Wiley-Blackwell Publishing Ltd

Tipo:
Review
Páginas:
582-602
Link para outro recurso:
www.scopus.com

Citações Recebidas na Web of Science: 92

Citações Recebidas na Scopus: 119

Documentos

  • Não há documentos

Métricas

Filiações mostrar / ocultar

Keywords

  • HELICOBACTER-PYLORI INFECTION; PROTON PUMP INHIBITORS; HUMAN GUT MICROBIOTA; INTESTINAL METAPLASIA; WEIGHT-LOSS; MOLECULAR CHARACTERIZATION; STOMACH MICROBIOTA; BARIATRIC SURGERY; BACTERIAL BIOTA; CANCER

Proyectos asociados

Unravelling Helicobacter pylori strategies to disrupt cell-cell junctions

Investigador Principal: Maria do Céu Fontes Herdeiro Figueiredo

Estudo Clínico Académico (Helicobacter) . 2019

Citar a publicação

Partilhar a publicação